1. Metabolic Enzyme/Protease
  2. Phosphodiesterase (PDE)
  3. PDE4-IN-32

PDE4-IN-32 (Compound B05) 是一种具有血脑屏障通透性的选择性 PDE4BPDE4D 抑制剂,对二者的 IC50 值分别为 13.7 nM 和 23.8 nM。PDE4-IN-32 可促进 MCAO/R 小鼠模型的运动和认知功能恢复。PDE4-IN-32 可减轻脑水肿。PDE4-IN-32 可用于缺血性脑卒中的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

PDE4-IN-32

PDE4-IN-32 Chemical Structure

CAS No. : 3080627-61-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PDE4-IN-32 (Compound B05) is a selective, blood-brain barrier permeable PDE4B and PDE4D inhibitor with IC50 values of 13.7 nM and 23.8 nM, respectively. PDE4-IN-32 promotes the recovery of motor and cognitive function in MCAO/R mouse models. PDE4-IN-32 reduces cerebral edema. PDE4-IN-32 can be used for the research of ischemic stroke[1].

IC50 & Target[1]

PDE4B

13.7 nM (IC50)

PDE4D

23.8 nM (IC50)

体外研究
(In Vitro)

PDE4-IN-32 可强效且选择性地抑制 PDE4 亚型,对 PDE4D 的 IC50 为 23.8 nM,对 PDE4B 的 IC50 为 13.7 nM,对其他 PDE 亚型的选择性超过 420 倍[1]
PDE4-IN-32 (0.156-1.25 μM; 1 h) 可呈剂量依赖性地保护 HT-22 小鼠海马神经元细胞免受 OGD/R 诱导的损伤[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

药代动力学
(Parmacokinetics)
Species Dose Route MRT0-t MRT0-∞ T1/2 Vz/F CLz/F Cmax Tmax Bioavailability
Rat[1] 2.0 mg/kg i.v. 2.12 ± 0.12 h 2.16 ± 0.11 h 3.06 ± 0.64 h 12.67 ± 3.2 L/kg 2.91 ± 0.69 L/h/kg 645.83 ± 147.20 μg/L / /
Rat[1] 20 mg/kg p.o. 8.76 ± 0.46 h 9.00 ± 0.52 h 3.14 ± 0.44 h 88.18 ± 28.95 L/kg 19.17 ± 4.55 L/h/kg 105.03 ± 41.59 μg/L 8.0 ± 0 h 15.5 %
体内研究
(In Vivo)

PDE4-IN-32 (60 mg/kg;口服;单次剂量) 不会在成年雄性比格犬中引发呕吐[1]
PDE4-IN-32 (2-30 mg/kg;腹腔注射) 可减小雄性 C57BL/6 小鼠在 MCAO/R 模型中的脑梗死体积,并以剂量依赖的方式减轻其脑梗死范围[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice (8-week-old male, middle cerebral artery occlusion and reperfusion)[1]
Dosage: 2 mg/kg; 10 mg/kg; 30 mg/kg
Administration: i.p.; single dose at reperfusion
Result: Did not significantly reduce infarct volume at 2 mg/kg dose.
Reduced corrected infarct volume to 26.26 ± 6.15% (vs 42.34 ± 2.32% in vehicle controls, p < 0.001) and increased ipsilateral/contralateral ADC ratio to 74.03 ± 2.317% (vs 67.36 ± 4.535% in vehicle controls, p < 0.05) at 10 mg/kg dose.
Reduced corrected infarct volume to 17.82 ± 2.994% (vs vehicle, p < 0.0001) and increased ipsilateral/contralateral ADC ratio to 81.96 ± 3.862% (vs vehicle, p < 0.0001; vs 10 mg/kg dose, p < 0.05) at 30 mg/kg dose.
分子量

320.34

Formula

C20H16O4

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PDE4-IN-32
目录号:
HY-181549
需求量: